TEST BANK d
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
d d d d d d d
Author: Teri Moser Woo and Wendy L. Wright
d d d d d d d
, TABLE OF CONTENT d d
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
d d d d d d d d d d
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
d d d d d d d
Chapter 3. Rational Drug Selection..................................................................................................................... 11
d d d d
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
d d d d d d d
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
d d d d
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
d d d d d
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
d d d d
Chapter 8. Herbal Therapies ................................................................................................................................ 28
d d d
Chapter 9. Cannabis ............................................................................................................................................ 31
d d
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
d d
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
d d d d d d d
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
d d d d d d d
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
d d d d d d d d
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
d d d d d d
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
d d d d d d
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
d d d d d d d d d
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
d d d d d d d
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
d d d d d d
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
d d d d d d d d d d d
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
d d d d d d d d d d d
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
d d d d d d
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
d d d d d d d
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
d d d d d d
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
d d d d d d d
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
d d d d d d d d d d
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
d d d d d d d
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
d d d d d d d d d
Chapter 28. Anemia .......................................................................................................................................... 113
d d
Chapter 29. Anxiety and Depression................................................................................................................. 116
d d d d
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
d d d d
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
d d d d
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
d d d d d
Chapter 33. Contraception ................................................................................................................................. 127
d d
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
d d d d d
Chapter 35. Dermatological Conditions ............................................................................................................ 134
d d d
Chapter 36. Diabetes Management ................................................................................................................... 138
d d d
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
d d d d d d d
Chapter 38. Headaches ...................................................................................................................................... 149
d d
Chapter 39. Heart Failure .................................................................................................................................. 153
d d d
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
d d d d d d d
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
d d d d
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
d d
Chapter 43. Hypertension .................................................................................................................................. 169
d d
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
d d d d
Chapter 45. Obesity ........................................................................................................................................... 177
d d
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
d d d d d d d
Chapter 47. Pneumonia ..................................................................................................................................... 185
d d
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
d d d d d d
Chapter 49. Substance Use Disorders ............................................................................................................... 190
d d d d
Chapter 50. Tuberculosis ................................................................................................................................... 195
d d
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
d d d d d d d d d d d d
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
d d d d
Chapter 53. Women as Patients......................................................................................................................... 203
d d d d
Chapter 54. Men as Patients .............................................................................................................................. 207
d d d d
Chapter 55. Pediatric Patients ........................................................................................................................... 209
d d d
Chapter 57. Geriatric Patients ........................................................................................................................... 213
d d d
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e d d d d Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
d d d d d d d d d d
MULTIPLE CHOICE d
1. Nurse practitioner prescriptive authority is regulated by:
d d d d d d
A. The National Council of State Boards of Nursing
d d d d d d d
B. The U.S. Drug Enforcement Administration
d d d d
C. The State Board of Nursing for each state
d d d d d d d
D. The State Board of Pharmacy
d d d d
ANS: C d PTS: d d 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
d d d d d d d d d d d d d
dinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
d d d d d d d d d d d
both in their basic nursing program and in their APRN program.
d d d d d d d d d d d
B. Nurses care for the patient from a holistic approach and include the patient in
d d d d d d d d d d d d d
decision-making regarding their care.
d d d d
C. APRNs are less likely to prescribe narcotics and other controlled substances.
d d d d d d d d d d
D. APRNs are able to prescribe independently in all states, whereas a physician’s
d d d d d d d d d d d
assistant needs to have a physician supervising their practice.
d d d d d d d d d
ANS: B d PTS: d d 1
3. Clinical judgment in prescribing includes:
d d d d
A. Factoring in the cost to the patient of the medication prescribed
d d d d d d d d d d
B. Always prescribing the newest medication available for the disease process
d d d d d d d d d
C. Handing out drug samples to poor patientsd d d d d d
D. Prescribing all generic medications to cut costs d d d d d d
ANS: A d PTS: d d 1
4. The process for choosing an effective drug for a disorder includes:
d d d d d d d d d d
A. Asking the patient what drug they think would work best for them
d d d d d d d d d d d
B. Consulting nationally recognized guidelines for disease management
d d d d d d
C. Prescribing medications that are available as samples before writing a prescription
d d d d d d d d d d
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
d d d d d d d
ANS: B d PTS: d d 1
5. Nonintentional nonadherence of drug therapy may occur due to:
d d d d d d d d
A. Belief that medication does not work
d d d d d
B. Adverse drug reactions d d
C. Chronic conditions that require daily therapy
d d d d d
D. Forgetfulness or distraction d d
ANS: D d PTS: d d 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
d d d d d d d
Author: Teri Moser Woo and Wendy L. Wright
d d d d d d d
, TABLE OF CONTENT d d
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
d d d d d d d d d d
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
d d d d d d d
Chapter 3. Rational Drug Selection..................................................................................................................... 11
d d d d
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
d d d d d d d
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
d d d d
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
d d d d d
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
d d d d
Chapter 8. Herbal Therapies ................................................................................................................................ 28
d d d
Chapter 9. Cannabis ............................................................................................................................................ 31
d d
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
d d
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
d d d d d d d
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
d d d d d d d
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
d d d d d d d d
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
d d d d d d
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
d d d d d d
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
d d d d d d d d d
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
d d d d d d d
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
d d d d d d
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
d d d d d d d d d d d
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
d d d d d d d d d d d
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
d d d d d d
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
d d d d d d d
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
d d d d d d
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
d d d d d d d
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
d d d d d d d d d d
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
d d d d d d d
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
d d d d d d d d d
Chapter 28. Anemia .......................................................................................................................................... 113
d d
Chapter 29. Anxiety and Depression................................................................................................................. 116
d d d d
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
d d d d
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
d d d d
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
d d d d d
Chapter 33. Contraception ................................................................................................................................. 127
d d
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
d d d d d
Chapter 35. Dermatological Conditions ............................................................................................................ 134
d d d
Chapter 36. Diabetes Management ................................................................................................................... 138
d d d
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
d d d d d d d
Chapter 38. Headaches ...................................................................................................................................... 149
d d
Chapter 39. Heart Failure .................................................................................................................................. 153
d d d
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
d d d d d d d
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
d d d d
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
d d
Chapter 43. Hypertension .................................................................................................................................. 169
d d
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
d d d d
Chapter 45. Obesity ........................................................................................................................................... 177
d d
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
d d d d d d d
Chapter 47. Pneumonia ..................................................................................................................................... 185
d d
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
d d d d d d
Chapter 49. Substance Use Disorders ............................................................................................................... 190
d d d d
Chapter 50. Tuberculosis ................................................................................................................................... 195
d d
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
d d d d d d d d d d d d
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
d d d d
Chapter 53. Women as Patients......................................................................................................................... 203
d d d d
Chapter 54. Men as Patients .............................................................................................................................. 207
d d d d
Chapter 55. Pediatric Patients ........................................................................................................................... 209
d d d
Chapter 57. Geriatric Patients ........................................................................................................................... 213
d d d
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e d d d d Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
d d d d d d d d d d
MULTIPLE CHOICE d
1. Nurse practitioner prescriptive authority is regulated by:
d d d d d d
A. The National Council of State Boards of Nursing
d d d d d d d
B. The U.S. Drug Enforcement Administration
d d d d
C. The State Board of Nursing for each state
d d d d d d d
D. The State Board of Pharmacy
d d d d
ANS: C d PTS: d d 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
d d d d d d d d d d d d d
dinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
d d d d d d d d d d d
both in their basic nursing program and in their APRN program.
d d d d d d d d d d d
B. Nurses care for the patient from a holistic approach and include the patient in
d d d d d d d d d d d d d
decision-making regarding their care.
d d d d
C. APRNs are less likely to prescribe narcotics and other controlled substances.
d d d d d d d d d d
D. APRNs are able to prescribe independently in all states, whereas a physician’s
d d d d d d d d d d d
assistant needs to have a physician supervising their practice.
d d d d d d d d d
ANS: B d PTS: d d 1
3. Clinical judgment in prescribing includes:
d d d d
A. Factoring in the cost to the patient of the medication prescribed
d d d d d d d d d d
B. Always prescribing the newest medication available for the disease process
d d d d d d d d d
C. Handing out drug samples to poor patientsd d d d d d
D. Prescribing all generic medications to cut costs d d d d d d
ANS: A d PTS: d d 1
4. The process for choosing an effective drug for a disorder includes:
d d d d d d d d d d
A. Asking the patient what drug they think would work best for them
d d d d d d d d d d d
B. Consulting nationally recognized guidelines for disease management
d d d d d d
C. Prescribing medications that are available as samples before writing a prescription
d d d d d d d d d d
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
d d d d d d d
ANS: B d PTS: d d 1
5. Nonintentional nonadherence of drug therapy may occur due to:
d d d d d d d d
A. Belief that medication does not work
d d d d d
B. Adverse drug reactions d d
C. Chronic conditions that require daily therapy
d d d d d
D. Forgetfulness or distraction d d
ANS: D d PTS: d d 1
